102 results match your criteria: "Hospital Vall Hebron[Affiliation]"
Epilepsy Res
May 2015
Epilepsy Unit, Department of Neurology, Hospital Vall Hebron, Barcelona, Spain; Neurovascular Research Unit, University Hospital Vall Hebron, Barcelona, Spain; Universitat Autònoma Barcelona (UAB), Barcelona, Spain.
Unlabelled: Patients with malignant middle cerebral artery (MCA) infarctions who have undergone craniectomy are susceptible to the development of vascular epilepsy. Our objective was to study the factors that might influence the occurrence of seizures in this group of patients.
Materials And Methods: All patients who developed malignant MCA infarction and had undergone decompressive craniectomy in our center between November 2002 and January 2014 were evaluated.
Front Public Health
December 2014
Icahn School of Medicine at Mount Sinai, New York, NY , USA.
NMR Biomed
January 2015
Liver Unit, Hospital Vall Hebron, Barcelona, Spain; Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (CIBEREHD), Instituto de Salud Carlos III, Madrid, Spain; Departament de Medicina, Universitat Autònoma de Barcelona, Cerdanyola del Vallès, Spain.
Intracranial hypertension is a severe complication of acute liver failure (ALF) secondary to brain edema. The pathogenesis of cerebral edema in ALF is not clear, but seems to be related to energy metabolism in which lactate may have an important role. The aim of this study was to follow the synthesis of brain lactate using a novel in vivo metabolic technology in a rat model of ALF.
View Article and Find Full Text PDFStroke
November 2014
From the M's Science Corporation, Kobe, Japan (R.U., W.S., S.M.); Moebius-Consult GmbH, Zurich, Switzerland (H.J.M.); Department of Neurology, University Hospital Ostrava, Ostrava, Czech Republic (D.S.); Neurovascular Unit, Hospital Vall Hebron, Barcelona, Spain (E.S.); and Institute of Neuroscience and Psychology, University of Glasgow, Southern General Hospital, Glasgow, Scotland, United Kingdom (K.W.M.).
Background And Purpose: The σ-1 receptor (Sig-1R) agonist cutamesine (SA4503) enhanced functional recovery after experimental stroke with a treatment initiation window of 48 hours and chronic treatment for 28 days. We conducted a phase 2 clinical trial exploring the safety, tolerability, dose range, and functional effects of cutamesine in patients with ischemic stroke.
Methods: Subjects were randomized between 48 and 72 hours after stroke to receive cutamesine 1 mg/d, 3 mg/d, or placebo for 28 days.
Background: Parenteral nutrition (PN) is a costly therapy that can also be associated with serious complications. Therefore, efforts are focusing on reducing rate of complications, and costs related to PN.
Objective: The aim was to analyze the effect of the implementation of PN standardization on costs and quality criteria.
World J Transplant
June 2014
Itxarone Bilbao, Cristina Dopazo, Jose Lazaro, Mireia Caralt, Gonzalo Sapisochin, Ramon Charco, Hepatobiliopancreatic Surgery and Liver Transplant Unit of the Department of General Surgery, Hospital Vall Hebrón, Universidad Autónoma Barcelona, 08035 Barcelona, Spain.
Background: Parenteral nutrition (PN) is a costly technology used widely to provide nutrition to patients who have an inaccessible or non-functioning intestine. Two all-in-one systems currently being used are customized formulations and three-compartment bags.
Objective: To provide a systematic cost comparison of the two all-in-one PN systems: individualized (made from nutrient solutions) versus commercialized (made from three-compartment bag), both prepared in hospital pharmacies.
Metab Brain Dis
December 2014
Liver Unit, Hospital Vall Hebron, Barcelona, Spain,
Brain alterations such as hepatic encephalopathy or brain edema are usually associated with liver failure. The mechanisms that lead to the generation of edema seem to be different depending on the course of liver failure (acute, chronic or acute-on-chronic liver failure). Several neuroimaging methods allow a non-invasive assessment of brain alterations in liver failure.
View Article and Find Full Text PDFClin Exp Dermatol
January 2014
Department of Dermatology, University Hospital Vall Hebron, Barcelona, Spain.
J Clin Gastroenterol
June 2014
*Liver Unit, Hospital Vall d'Hebron †Department of Medicine, Universitat Autònoma de Barcelona ‡Laboratori de Metabolopaties, Hospital Universitari Vall d'Hebron §UCICAC, Vall Hebron Institut of Research ∥Pharmacy, Hospital Vall Hebron #Liver Unit, Hospital Sant Pau, Barcelona ¶CIBEREHD, Instituto de Salud Carlos III, Madrid, Spain.
Aims: Confirm in patients with cirrhosis and gastrointestinal bleeding the safety of ornithine phenylacetate (OP) and assess the pharmacokinetic profile of OP and its effects on plasma ammonia.
Background: OP is a drug that has shown experimentally to decrease hyperammonemia and improve hepatic encephalopathy. OP is safe in healthy subjects and in stable patients with cirrhosis, but there are no data in decompensated cirrhosis.
Transl Lung Cancer Res
June 2013
IOR, Dexeus University Institute, Barcelona, Spain ;
It is widely acknowledged that there is a need for molecular profiling in non-small-cell lung cancer. For example, treatment based on EGFR mutation status has attained successful results. However, in spite of excellent initial response to oral EGFR tyrosine kinase inhibitors (TKIs), progression-free survival is still limited.
View Article and Find Full Text PDFSubst Abus
January 2014
Outpatient Drug Clinic Vall Hebron, Department of Psychiatry, University Hospital Vall Hebron-ASPB, Barcelona, Spain.
Background: Psychotic symptoms are common among cocaine users.
Methods: An observational naturalistic study on the effects and events of intravenous cocaine use in a drug consumption room was carried out; the patients were diagnosed of cocaine dependence (according to the Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition, Text Revision).
Results: Twenty-one patients, 81% men self-injected cocaine 375 times.
Liver Int
February 2013
Liver Unit, Hospital Vall Hebron, Barcelona, Spain.
Background & Aim: Acute-on-chronic liver failure is the term that refers to sustained liver injury with acute decompensation, usually induced by a precipitating factor. A common link between ensuing failures of various organs is impairment of the vascular supply, which may also induce vasogenic oedema in the brain. The aim of this study was to perform magnetic resonance (MR) study of the brain in a rat model combining bile duct ligation (BDL) and lipopolysaccharide (LPS) administration to investigate brain oedema in liver failure.
View Article and Find Full Text PDFMetab Brain Dis
June 2013
Liver Unit, Hospital Vall Hebron, Barcelona, Spain.
Liver transplantation (LT) candidates experience frequently episodic or persistent hepatic encephalopathy. In addition, these patients can exhibit neurological comorbidities that contribute to cognitive impairment in the pre-transplant period. Assessment of the respective contribution of hepatic encephalopathy or comorbidities in the cognitive manifestations is critical to estimate the neurological benefits of restoring liver function.
View Article and Find Full Text PDFJ Neurol
December 2012
Neurovascular Unit, Hospital Vall Hebron, Barcelona, Spain.
The risk of recurrent stroke is likely related to etiology. Therefore it is important to identify which patients are at highest early risk. We evaluated whether selected blood biomarkers may aid in the diagnosis of stroke etiology.
View Article and Find Full Text PDFAJNR Am J Neuroradiol
September 2011
Liver Unit, Hospital Vall Hebron, Barcelona, Spain.
Background And Purpose: DTI has shown increased MD of water molecules in the brain of patients with cirrhosis, consistent with low-grade edema. This study further characterizes this edema by using biexponential analysis of DTI data, a technique that may differentiate cytotoxic and vasogenic edema.
Materials And Methods: A total of 41 patients with cirrhosis awaiting liver transplantation and 16 healthy controls were studied by DTI by using a single-shot echo-planar technique with 11 b-values (range, 0-7500 s/mm(2)) and 6 noncollinear directions.
EuroIntervention
June 2011
Hospital Vall Hebrón, Hospital Vall Hebrón, Barcelona, Spain.
Aims: To evaluate the feasibility and safety of the Nile Croco® coronary bifurcation stent system (Minvasys, Gennevilliers, France).
Methods And Results: The primary endpoint was to assess the acute device success and angiographic success with the use of the Nile Croco® stent system. Secondary endpoints included in-hospital and six month major cardiac events (MACE).
Actas Esp Psiquiatr
April 2010
Servicio de Psiquiatría, Escuela de Enfermería 5 planta, Hospital Vall Hebrón, Paseo de Vall Hebrón 119-129, 08035 Barcelona, Spain.
The disorders classified as control of the impulses; explosive intermittent disorder, pathological gambling, kleptomania, pyromania, pathological gambling, hair pullers, compulsive purchases, skin picking and onychophagia are a heterogeneous set of clinical entities, most of them with little prevalence. Nevertheless, they cause important personal and social dysfunctions and present great comorbidity with other psychiatric disorders. Antipsychotics, antidepressive agents, serotoninergic agonists, naltrexone, beta blockers antiandrogen, lithium and anticonvulsants have been used in their pharmacological treatment.
View Article and Find Full Text PDFGastroenterology
April 2010
Liver Unit, Hospital Vall Hebron, Barcelona, Spain.
Background & Aims: Brain edema is a severe complication of acute liver failure (ALF) that has been related to ammonia concentrations. Two mechanisms have been proposed in the pathogenesis: vasogenic edema that is secondary to the breakdown of the blood-brain barrier and cytotoxic edema caused by ammonia metabolites in astrocytes.
Methods: We applied magnetic resonance techniques to assess the intracellular or extracellular distribution of brain water and metabolites in a rat model of devascularized ALF.
Transplant Proc
April 2009
Department of Hepatobiliopancreatic Surgery and Transplants, Hospital Vall Hebrón, Universidad Autónoma Barcelona, Barcelona, Spain.
Objective: To report a severe interaction between simvastatin and rapamycin resulting in rhabdomyolysis and acute renal failure in a liver transplant patient.
Background: A 56-year-old man with hepatitis C virus cirrhosis (Child B) was diagnosed with hepatocellular carcinoma and underwent liver transplantation in April 2007. He was immunosuppressed with tacrolimus (FK) and mycophenolate mofetil (MMF).
Int Immunopharmacol
December 2006
Liver Transplantation Unit of the Department of General Surgery, Hospital Vall Hebrón, Universidad Autónoma Barcelona, Spain.
Aim: To analyze our results with mycophenolate mofetil (MMF) in stable liver transplantation (LT) patients presenting with adverse events (AE) related to prolonged use of calcineurin inhibitors (CNI).
Methods: Conversion to MMF was performed in 56 out of 323 LT patients from 91-02: 24 (43%) were converted to MMF in monotherapy and 32 (57%) to MMF+low doses of CNI. The indication for conversion was chronic renal insufficiency (CRI) in all patients.
An Otorrinolaringol Ibero Am
July 2006
Unidad de Sueño, Servicio de Neurofisiología Clínica. Hospital Vall Hebrón, Barcelona, España.
The obstructive sleep apnea syndrome (OSAS) is frequent in infancy and childhood. It is caused by a prolonged upper respiratory airway obstructioon during sleep, and adenotonsillar hypertrophy is the most important cause. OSAS may have an impact on physical and cognitive development, but syntoms in children are subtle and may pass unrecognised.
View Article and Find Full Text PDFTransplant Proc
November 2005
Unidad de Trasplante Hepático, Hospital Vall Hebrón, Universidad Autonoma, Barcelona, Spain.
The aim was to study the advantages of the use of a temporary portacaval shunt (PCS) with inferior vena cava (IVC) preservation during the piggyback technique for the anhepatic phase of orthotopic liver transplantation (OLT) performed in cirrhotic patients. Two groups of cirrhotic patients who underwent OLT with piggyback technique were compared; one with a PCS (n = 57) and the other, without PCS (n = 54). Patients with fulminant hepatitis, retransplantation, portal thrombosis, and previous portosystemic shunts were excluded.
View Article and Find Full Text PDFTranspl Int
December 2005
Liver Transplantation Unit, Department of General Surgery, Hospital Vall Hebrón, Universidad Autónoma Barcelona, Barcelona, Spain.
The aim of this prospective randomized trial was to study the efficacy and safety of tacrolimus monotherapy (TACRO) and compare it with our standard treatment of tacrolimus plus steroids (TACRO + ST) after liver transplant (LT). Furthermore, the impact of steroid-free immunosuppression on outcome of hepatitis C virus (HCV) was analysed. Between 1998 and 2000, 60 patients (mean age: 57 years) were included in the study and randomized to receive TACRO (n = 28) or TACRO + ST (n = 32).
View Article and Find Full Text PDF